Background
==========

Protease-activated receptor-2 (PAR-2) is one of a family of G-protein coupled transmembrane receptors activated by proteolytic release of a \'tethered\' ligand. We previously reported this receptor has a pivotal role in chronic joint inflammation using a PAR-2 \'knockout\' mouse \[[@B1]\], but the serine protease responsible for its activation remains uncertain.

Objective
=========

We investigated whether β-tryptase has proinflammatory actions in the mouse knee and specifically whether a tryptase inhibitor can modulate experimentally induced chronic joint inflammation.

Methods
=======

Five micrograms of human β-tryptase was injected into the knee joint cavity of two groups of anaesthetized (Halothane/O~2~/N~2~O) mice (30 g): wild-type (PAR-2^+/+^) C57BL/6J mice and PAR-2 gene disrupted mice (PAR-2^-/-^). Joint swelling was assessed by comparing caliper measurements of knee joint diameter pre-injection and post-injection. Chronic monoarthritis was induced using the same anaesthetic regime in separate wild-type mice by intra-articular and peri-articular injection of Freunds complete adjuvant (FCA) (in 5% methycellulose). In a parallel group of mice, 50 μg of the tryptase inhibitor 4-amidino phenyl pyruvic acid (APPA) was co-administered with the FCA/methycellulose emulsion. Joint diameter was measured over 10 days.

Results
=======

Intra-articular injection of β-tryptase resulted in rapid joint swelling in wild-type mice that was completely abrogated in PAR-2^-/-^mice (Fig. [1a](#F1){ref-type="fig"}), suggesting that tryptase-mediated inflammatory actions require functional PAR-2. Tryptase plays an important role in mediating chronic inflammation as APPA co-administration substantially inhibited FCA-induced joint swelling (Fig. [1b](#F1){ref-type="fig"}). The present study extends our previous finding \[[@B1]\] that PAR-2 plays a key role in mediating chronic joint inflammation, by demonstrating that tryptase may be a crucial activating protease required for such PAR-2-mediated actions.

![**(a)**Six hours after intra-articular injection of β-tryptase, knee joint swelling is evident in wild-type (PAR-2^+/+^) mice but is virtually absent in PAR-2 gene disrupted (PAR-2^-/-^) mice (*P*\< 0.001, *n*= 4). **(b)**Knee joint swelling 10 days after Freunds complete adjuvant (FCA) treatment is significantly inhibited by co-administration of 4-amidino phenyl pyruvic acid (APPA) with FCA (*P*= 0.014, *n*= 4).](ar1620-1){#F1}
